There has been no examination as to whether the prevalence of complementary and alternative medicine (CAM) use, as well as personal factors associated with CAM use and predictive of CAM use for women with female-specific cancers, is similar to those in other diagnostic groups. The purpose of this review is to compare CAM use and personal factors associated with and predictive of CAM use by women with female-specific cancers to samples of other diagnostic groups. If it is the case that CAM use is similar across various types of samples, then it may be unnecessary to continue to study detailed CAM use by those in separate diagnostic groups and instead focus energies on the examination of CAM therapies that may have risks for interaction with conventional therapies, such as biologically based therapies. The researcher concludes that we are now in an era in which we need to use our restricted time, human resources, and finances to examine biologically based CAM use that may carry high risks for interactions or toxicities for specific groups under examination, rather than examine global CAM use, unless the situation warrants such all-inclusive study.
National Center for Complementary and Alternative Medicine. What Is Complementary and Alternative Medicine?2002. Available at: http://nccam.nih.gov/health/whatiscam/ .Accessed December 15, 2006.
2.
Curtis P., Gaylord S.Safety issues in the interaction of conventional, complementary, and alternative health care. Complement Health Pract Rev. 2005;10:3-31.
3.
Dasgupta A., Bernard DWHerbal remedies: effects on clinical laboratory tests. Arch Pathol Lab Med.2006;130:521-528.
4.
Labriola D., Livingston R.Possible interactions between dietary antioxidants and chemotherapy. Oncology. 1999;13:1003-1012.
5.
Meijerman I. , Beilnen JH, Schellens JHHerb-drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006 ;11:742-752.
6.
Cornelli MC, Mengs U., Schneider C., Prosdocimi M.Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy. Integr Cancer Ther.2007;6:120-129.
7.
Eschiti VSComplementary and Alternative Modalities Used by Women With Female-Specific Cancers [Dissertation]. Denton, Tex: Texas Womans University; 2007.
8.
National Cancer Institute. Complementary and Alternative Medicine in Cancer Treatment. Available at: http://www.cancer.gov/cancerinfo/pdq/cam.Accessed December 26, 2006.
9.
Tasaki K., Maskarinec G., Shumay D., Tatsumura Y., Kakai H.Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psycho-oncology . 2002;11:212-220.
10.
Vickers KA, Jolly KB, Greenfield SMHerbal medicine: Women's views, knowledge, and interaction with doctors: a qualitative study. BMC Complement Altern Med.2006;6:40. Available at http://www.biomedcentral.com/1472-6882/6/40 . Accessed December 1, 2006.
11.
Briere C., Dal Bello D., Fung Kee Fung M., Chambers A.Alternative and Complementary Therapy in the Prevention and Management of Gynecologic Cancers: Special Report #4-7. Ontario: Cancer Care Ontario; 2004. Available at: http://www.cancer-care.on.ca/pdf/pebc4-7s.pdf. Accessed December 1, 2006.
12.
von Gruenigen VE, Hopkins MPAlternative medicine in gynecologic oncology: a case report. Gynecol Oncol.2000;77:190-192.
13.
Weiger WA, Smith M., Boon H., Richardson MA, Kaptchuk TJ, Eisernberg DMAdvising patients who seek complementary and alternative therapies for cancer . Ann Intern Med.2002;137: 889-903.
14.
Adler SR, Fosket JRDisclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract.1999;48:453-458.
15.
Alferi SM, Antoni MH, Ironson G., Kilbourn KM, Carver CSFactors predicting the use of complementary therapies in a multi-ethnic sample of early-stage breast cancer patients. JAMWA. 2001;56:120-123.
16.
Burnstein HJ , Gelber S., Guadagnoli E., Weeks JCUse of alternative medicine by women with early-stage breast cancer. N Engl J Med.1999 ;340:1733-1739.
17.
Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D.Alternative therapies used by women with breast cancer in four ethnic populations . J Natl Cancer Inst.2000;92:42-47.
18.
Morris KT, Johnson N., Homer L., Walts D.A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg.2000; 179:407-411.
19.
VandeCreek L., Rogers E., Lester J.Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med.1999;5:71-76.
20.
Lengacher CA , Bennett MP, Kip KE, Berarducci A., Cox CEDesign and testing of the use of a complementary and alternative therapies survey in women with breast cancer. Oncol Nurs Forum.2003;30:811-821.
21.
Ashinkaga T. , Bosompra K., O-Brien P, Nelson L. Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10:542-548.
22.
Bauer-Wu S. , Gross A., Liu Q.Prevalence and predictors of complementary and alternative therapies use by women with advanced breast cancer [abstract] . Oncol Nurs Forum.2006;33: 470-471.
23.
DiGianni LM , Kim HT, Emmons K., Gelman R., Kalkbrenner KJ, Garber JEComplementary medicine use among women enrolled in a genetic testing program. Cancer Epidemiol Biomarkers Prev. 2003;12:321-326.
24.
Hann D., Baker F., Denniston M., Entrekin N.Long-term breast cancer survivors' use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integr Cancer Ther.2005;4:14-20.
25.
Hann DM, Baker F., Roberts CS, et al. Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study. Integr Cancer Ther.2005;4:294-300.
26.
Hann D., Allen S., Ciambrone D., Shah A.Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist. Integr Cancer Ther.2006;5:224-231.
27.
Henderson JW , Donatelle RJComplementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med.2004;10:52-57.
28.
Lengacher CA , Bennett MP, Kip KE, et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum.2002;29:1445-1452.
29.
Lengacher CA , Bennett MP, Kip KE, Gonzalez L., Jacobsen P., Cox CERelief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum.2006;33:97-104.
30.
Nahleh Z., Tabbara IAComplementary and alternative medicine in breast cancer patients. Palliat Support Care. 2003;1:267-273.
31.
Navo MA, Phan J., Vaughan C., et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol.2004;22:671-677.
32.
Patterson, RE, Neuhouser, ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med.2002;8:477-485.
33.
Shen J., Andersen R., Albert PS, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med.2002. Available at: http://www.biomedcentral.com/1472-6882/2/8 . Accessed September 28, 2004.
34.
Rakovitch E. , Pignol J., Chartier C., et al. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death . Breast Cancer Res Treat.2005;90:139-148.
35.
UT Medical Group.Gynecological Cancers. Available at: http://www.utmedicalgroup.com/pages/top_gyncancer.html#TextAnchor1. Accessed December 27, 2005.
36.
McKay DJ , Bentley JR, Grimshaw RNComplementary and alternative medicine in gynaecologic oncology. J Obstet Gynaecol Cancer. 2005;27:562-568.
37.
Molassiotis A., Browall M., Milovics L., Panteli V., Patiraki E., Fernandez-Ortega P.Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecol Cancer. 2006;16(suppl 1):219-224.
38.
Powell CB, Dibble SL, Dall'Era JE, Cohen I. Use of herbs in women diagnosed with ovarian cancer . Int J Gynecol Cancer. 2002;12:214-217.
39.
Swisher EM, Cohn DE, Goff BA, et al. Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol.2002;84:363-367.
40.
von Gruenigen VE, White LJ, Kirven MS, Showalter AL, Hopkins MP, Jenison, ELA comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer. 2001;11:205-209.
41.
von Gruenigen VE, Frasure HE, Jenison EL, Hopkins MP, Gil KMLongitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol.2006;103:120-126.
42.
Wenner CA, Parker K., Simon MA, Adams L., Greene K., Standish LJBotanical medicines with gynecological anticancer activity: a literature review . JAMWA. 1999;54:184-190.
43.
Granai COExpectations about alternative therapies and women with gynecological cancer . Curr Opin Obstet Gynecol.1999;11:3-10.
44.
Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PRTotal and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 ;66:1223-1228.
45.
Wilkinson S. , Gomella LG, Smith JA, et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol.2002;168:2505-2509.
46.
Hedderson MM , Patterson RE, Neuhouser ML, et al. Sex differences in motives for use of complementary and alternative medicine among cancer patients. Altern Ther Health Med.2004;10:58-64.
47.
Greenlee H. , White E., Patterson RE, Kristal ARSupplement use among cancer survivors in the vitamins and lifestyle (VITAL) study cohort. J Altern Complement Med.2004;10: 160-166.
48.
Barnes PM, Powell-Grinner E., McFann K., Nahin RLComplementary and Alternative Medicine Use Among Adults: United States, 2002 (DHHS Publication No. 2004-1250-04-0342). Hyattsville, Md: US Department of Health and Human Services; 2004.
49.
Grzywacz JG, Lang W., Suerken C., Quandt SA, Bell RA, Arcury TAAge, race, and ethnicity in the use of complementary and alternative medicine for health self-management: evidence from the 2002 National Health Interview Survey. J Aging Health. 2005;17:547-572.
50.
Cherrington A. , Lewis CE, McCreath HE, Herman CJ, Richter DL, Byrd T.Association of complementary and alternative medicine use, demographic factors, and perimenopausal symptoms in a multiethnic sample of women. Fam Community Health. 2003 ; 26:74-83.
51.
Garrow D., Egede LEAssociation between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes. Diabetes Care. 2006;29:15-19.
52.
Herman CJ, Allen P., Hunt WC, Prasad A., Brady TJUse of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis [serial online]. 2004;1. Available at: http://www.cdc.gov/pcd/issues/2004/oct/03_0036.htm. Accessed December 15, 2006.
53.
Langmead L. , Chitnis M., Rampton DSUse of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis. 2002;8:174-179.
54.
Lind BK, Lafferty WE, Grabowske DE, Diehr PKComplementary and alternative provider use by insured patients with diabetes in Washington state. J Altern Complement Med.2006;12:71-77.
55.
Raphael KG, Klausner JJ, Nayak S., Marbach JJComplementary and alternative therapy use by patients with myofascial temporomandibular disorders. J OrofacPain. 2003;17:36-41.
56.
Simon GE, Cherkin DC, Sherman KJ, Eisenberg DM, Deyo RA, Davis RBMental health visits to complementary and alternative medicine providers. Gen Hosp Psychiatry. 2004;36:171-177.
57.
Vardeny O., Bromberg MBThe use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS). J HerbPharmacol.2005;5:23-31.
58.
Rajendran PR , Thompson RE, Reich SGThe use of alternative therapies by patients with Parkinson's disease. Neurology. 2001;57:790-794.
59.
Zick SM, Blume A., Aaronson KDThe prevalence and patterns of complementary and alternative supplement use in individuals with chronic heart failure. J Card Fail. 2005;11:586-589.
60.
Peebles CT, McAuley JW, Roach J., Moore JL, Reeves ALAlternative medicine use by patients with epilepsy. E&B.2000;1:74-77.
61.
Sirven JI, Drazkowski JF, Zimmerman RS, Bortz JJ, Shulman DL, Macleish M.Complementary/alternative medicine for epilepsy in Arizona. Neurology. 2003;61:576-577.
62.
Pearson NJ, Johnson LL, Nahin RLInsomnia, trouble sleeping, and complementary and alternative medicine: analysis of the 2002 National Health Interview Survey data. Arch Intern Med.2006;166:1775-1782.
63.
Yeh GY, Eisenberg DM, Davis RB, Phillips RSUse of complementary and alternative medicine in patients with cardiovascular disease. Am J Cardiol.2006;98:673-680.
64.
Schwartz CE , Laitin E., Brotman S., LaRocca N.Utilization of unconventional treatments by persons with MS: is it alternative or complementary?Neurology . 1999;52:626-629.
65.
Kong SC, Hurlstone DP, Pocock CY, et al. The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol.2006;39:138-141.
66.
Koloski NA, Talley NJ, Huskic SS, Boyce PMPredictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther.2003;17:841-851.
67.
Hsiao AF, Wong MD, Kanouse DE, et al. Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Synd. 2003;33:157-165.
68.
McEachrane-Gross FP, Liebschutz JM, Berlowitz D.Use of selected complementary and alternative medicine (CAM) treatments in veterans with cancer or chronic pain: a cross-sectional survey. BMC Complement Altern Med.2006;6:34. Available at: http://www.biomedcentral.com/1472-6882-6-34. Accessed December 15, 2006.
69.
Kleshinski JF, Crews C., Fry E., et al. A survey of herbal product use in a dialysis population in northwest Ohio. J Ren Nutr. 2003;13:93-97.
70.
Rossi P., Di Lorenzo G., Faroni J., Malpezzi MG, Cesarino F., Nappi G.Use of complementary and alternative medicine by patients with chronic tension-type headache: results of a headache clinic survey. Headache. 2006;46:622-631.
71.
Bell RA, Stafford JM, Arcury TA, et al. Complementary and alternative medicine use and diabetes self-management among rural older adults. Complement Health Pract Rev. 2006;11: 95-106.
72.
Dente JM, Herman CJ, Allen P., Hunt WCEthnic differences in the use of complementary and alternative therapies among adults with osteoarthritis. Prev Chronic Dis [serial online] . 2006;3(3). Available at: http://www.dcd.gov/pcd/issues/2006/jul/05_0231.htm. Accessed December 15, 2006.
73.
Manheimer E. , Anderson BJ, Stein MDUse and assessment of complementary and alternative therapies by intravenous drug users. Am J Drug Alcohol Abuse . 2003;29:401-414.
74.
Marrie RA, Hadjimichael O., Vollmer T.Predictors of alternative medicine use by multiple sclerosis patients. Mult Scler.2003;9:461-466.
75.
Jermewall N. , Zea M., Reisen CA, Poppen PJComplementary and alternative medicine and adherence to care among HIVpositive Latino gay and bisexual men. AIDS Care. 2005;17: 601-609.
76.
Coleman LM, Fowler LL, Williams MFUse of unproven therapies by people with Alzheimer's disease. J Am Geriatr Soc.1995;43:747-750.
77.
Ko J., Lee JL, Muñoz-Furlong A., Li X., Sicherer SHUse of complementary and alternative medicine by food-allergic patients. Ann Allergy Asthma Immunol.2006;97:365-369.
78.
George M., Birck K., Hufford DJ, Jemmott LS, Weaver TEBeliefs about asthma and complementary and alternative medicine in low-income inner-city African-American adults. J Gen Intern Med. 2006;21:1317-1324.
79.
Grabe DW, Garrison GDComparison of natural product use between primary care and nephrology patients . Ann Pharmacother.2004;38:1169-1172.
80.
Kessler RC, Soukup J., Davis RB, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry.2001;158:289-294.
